Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
---|
06/26/2003 | CA2468978A1 Therapeutic heterocycles |
06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/25/2003 | CN1425648A Process for preparing biurea |
06/24/2003 | US6583319 Cyclic compounds having a cycloalkylene chain |
06/24/2003 | US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
06/24/2003 | US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
06/19/2003 | WO2003050066A1 Functionalized higher diamondoids |
06/19/2003 | US20030114532 Contacting human or nonhuman animal skin or hair with a compound containing 1-(3-methoxybenzyl)-3-substituted thiourea for for inhibiting free radical degradation |
06/19/2003 | US20030114517 Substituted urea neuropeptide Y Y5 receptor antagonists |
06/19/2003 | US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
06/19/2003 | US20030114447 Controlling apoptosis; central nervous system disorders |
06/19/2003 | CA2469858A1 Functionalized higher diamondoids |
06/18/2003 | EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof |
06/18/2003 | EP1318974A2 Resorcinol derivatives |
06/12/2003 | WO2003048115A1 Bacterial enzyme inhibitors |
06/12/2003 | WO2003048108A2 Compounds for treatment of inflammation, diabetes and related disorders |
06/12/2003 | WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
06/12/2003 | WO2002017712A3 Disubstituted benzenes as insecticides |
06/12/2003 | US20030109716 5-acylamino-2-amino-4-substituted-phenol compounds and method of using them |
06/12/2003 | US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
06/12/2003 | US20030109516 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof |
06/12/2003 | US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4. |
06/12/2003 | CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
06/11/2003 | EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents |
06/11/2003 | EP1105372B1 Methoximinophenylacetic acid amides |
06/10/2003 | US6576780 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
06/10/2003 | CA2304713C Biphenyl-5-alkanoic acid derivatives and use thereof |
06/10/2003 | CA2094542C Method for treating ammonia and urea condensates |
06/10/2003 | CA2055670C Retroviral protease inhibiting compounds |
06/05/2003 | US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
06/05/2003 | US20030105091 Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
06/04/2003 | EP1316544A1 5-acylamino-2-amino-4-substituted-phenol compounds and method of using them |
06/04/2003 | EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof |
05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
05/29/2003 | US20030100626 Rheological aids based on urea urethanes; polyesters having amine and hydroxy end groups crossed linked by a diisocyanate; automobile coatings; seals; adhesives; storage stability |
05/29/2003 | US20030100613 Substituted imide derivatives |
05/29/2003 | US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid |
05/29/2003 | US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
05/28/2003 | EP1314721A1 Novel propenohydroxamic acid derivatives |
05/28/2003 | EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
05/28/2003 | EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
05/28/2003 | CN1420863A Substd. imide derivs. |
05/27/2003 | US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors |
05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
05/22/2003 | US20030096864 Compounds to treat alzheimer's disease |
05/22/2003 | US20030096847 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia |
05/22/2003 | US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |
05/21/2003 | EP1312602A1 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them |
05/21/2003 | EP1311475A1 Novel aminocyclohexane derivatives |
05/20/2003 | US6566509 Compound for use as bactericide |
05/20/2003 | CA2110693C Amino acid derivative anticonvulsant |
05/15/2003 | WO2003005965A3 Modulators of ceramidase and methods of use based thereon |
05/15/2003 | WO2002100836A3 Compounds, compositions and methods for modulating beta-amyloid production |
05/15/2003 | US20030092715 Aryl and biaryl compounds having MCH modulatory activity |
05/15/2003 | US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases |
05/15/2003 | US20030092634 Novel compounds and compositions as protease inhibitors |
05/14/2003 | EP1309595A2 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo(1,2-a) imidazol-2-one |
05/14/2003 | CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
05/13/2003 | US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
05/08/2003 | WO2003037865A1 Novel anticancer compounds |
05/08/2003 | US20030088122 Method of preparing amino carboxylic acids |
05/08/2003 | US20030087956 Useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor alpha 4 beta 1. |
05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
05/08/2003 | CA2468761A1 Novel anticancer compounds |
05/07/2003 | EP1308438A1 3-substituted urea derivatives and medicinal use thereof |
05/07/2003 | EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides |
05/07/2003 | EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers |
05/07/2003 | EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
05/07/2003 | CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia |
05/06/2003 | US6559181 A method to treat endometrial carcinoma, prostate cancer, or prostate hyperplasia comprising administering to a patient in need of such treatment an effective dose of a 3,4-Diphenyl-bicyclo(4.3.0)nonyl compound of formula I |
05/02/2003 | EP1305301A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
05/01/2003 | WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE |
05/01/2003 | WO2003011223A3 Immunomodulatory compounds and methods of use thereof |
05/01/2003 | WO2002026701A3 Ionic liquids and their use as solvents |
05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
05/01/2003 | US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease |
05/01/2003 | US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity |
04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
04/29/2003 | US6555580 Treating arteriosclerosis and hypercholesterolaemia |
04/24/2003 | US20030078249 VLA-4 inhibitor compounds |
04/23/2003 | EP1303503A2 Aniline derivatives |
04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
04/23/2003 | EP1303481A1 Phenylethylamine derivatives and their use in the treatment of melanoma |
04/23/2003 | CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
04/23/2003 | CN1413187A Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
04/22/2003 | US6552092 Urea derivatives as hyrophobic particles obtained by crystallization from a clear homogeneous melt dispersed in a carrier; printing inks; cooling lubricants; |
04/22/2003 | US6551600 Immunological adjuvant compounds compositions and methods of use thereof |
04/22/2003 | CA2141874C Process for the production of urea granules |
04/17/2003 | WO2003030889A1 Para-amino benzoic acids as integrin antagonists |
04/17/2003 | WO2000037430A3 Use of androgen receptor suppressors |
04/17/2003 | WO1998003518A3 New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity |
04/17/2003 | US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents |
04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |
04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
04/16/2003 | EP1302461A1 Tnf-alpha production inhibitors |
04/16/2003 | EP1301467A2 9-substituted minocycline compounds |
04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |